- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 477/14 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycinsSuch ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
Patent holdings for IPC class C07D 477/14
Total number of patents in this class: 17
10-year publication summary
|
0
|
2
|
0
|
2
|
2
|
2
|
0
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Diverse Biotech, Inc. | 18 |
2 |
| The Regents of the University of California | 20590 |
1 |
| Centre National de La Recherche Scientifique | 10914 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6615 |
1 |
| Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V. | 5202 |
1 |
| East China University of Science and Technology | 545 |
1 |
| Ecole Normale Superieure de Lyon | 246 |
1 |
| FOB Synthesis, Inc. | 2 |
1 |
| Hans R. Pfaendler | 1 |
1 |
| Lek Pharmaceuticals d.d. | 188 |
1 |
| Universite Claude Bernard Lyon 1 | 1068 |
1 |
| The University of Hong Kong | 825 |
1 |
| Hans Rudolf Pfaendler | 1 |
1 |
| Molsid | 12 |
1 |
| Fob Synthesis | 1 |
1 |
| Choi, Woo-baeg, Dr. | 3 |
1 |
| Other owners | 0 |